The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Atmospheric & Environmental Changes Tied to Organ-Specific Lupus Flares

Atmospheric & Environmental Changes Tied to Organ-Specific Lupus Flares

November 19, 2019 • By Megan Brooks

  • Tweet
  • Email
Print-Friendly Version / Save PDF

NEW YORK (Reuters Health)—Changes in atmospheric and environmental factors may contribute to organ-specific disease exacerbation in patients with systemic lupus erythematosus (SLE), according to a new study.

You Might Also Like
  • Local Depletion of Resident Memory T Cells May Reduce Site-Specific Joint Flares
  • Lupus Flares Pose Greatest Risk for Adverse Pregnancy Outcomes in Women with SLE
  • Naive B Cells Activate & Expand During Lupus Flares

The study found “strong associations between atmospheric variables and fine particulate matter concentration over the 10 days prior to a patient visit and organ-specific lupus flares at the visit,” lead researcher George Stojan, MD, of the Johns Hopkins Lupus Center in Baltimore reported Nov. 9 at the 2019 ACR/ARP Annual Meeting in Atlanta.1

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“The seasonality of lupus flares is likely the result of atmospheric and climate factors. These findings may have wide ranging clinical and epidemiological implications,” he reports.

Using data from the U.S. Environmental Protection Agency (EPA), the researchers examined the effects of fine particulate matter (PM2.5) concentration, temperature, relative humidity, winds, ozone concentration and barometric pressure on the flare ups associated with different organs in more than 1,600 patients with SLE. They calculated the average values for each factor 10 days prior to a patient visit.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

In multivariate analysis, there were statistically significant associations between environmental factors and lupus activity. Rash, serositis, hematologic and joint flares were all associated with an increase in temperature. Renal flares decreased as the temperature and ozone concentration increased.

Joint, neurologic, renal, hematologic and pulmonary flares were directly associated with residual wind, and humidity was significantly associated with joint and serositis flares.

PM2.5 concentration was significantly associated with rash, joints, serositis and hematologic flares. Barometric pressure had no significant associations.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

“These data could add an important aspect to lupus trials, the outcomes of which may be affected by so far unrecognized environmental factors, and ultimately it could allow predictive modeling of lupus flares which would revolutionize the approach to treatment,” the authors write in the meeting abstract.

Dr. Stojan tells Reuters Health, “It’s too early to infer any definite connection between the environmental factors we analyzed and lupus flares. If confirmed, the implications could be profound and could change our understanding of the interaction of our immune system with the environment leading to better clinical trial design and new potential therapeutic options.”

“We are just beginning to understand how our immune system is affected by external factors but I do believe this is a very exciting field,” he adds.

The study had no commercial funding and the authors have no relevant disclosures.


Reference

  1. Stojan G, Curriero F, Kvit A, et al. Environmental and atmospheric factors in systemic lupus erythematosus: A regression analysis [abstract #695]. Arthritis Rheumatol. 2019 Oct; 71(suppl 10).

Pages: 1 2 | Single Page

Filed Under: Conditions, SLE (Lupus) Tagged With: 2019 ACR/ARP Annual Meeting, environmental factor, Flares, Lupus, systemic lupus erythematosus (SLE)

You Might Also Like:
  • Local Depletion of Resident Memory T Cells May Reduce Site-Specific Joint Flares
  • Lupus Flares Pose Greatest Risk for Adverse Pregnancy Outcomes in Women with SLE
  • Naive B Cells Activate & Expand During Lupus Flares
  • Sleep Apnea Tied to Gout Flares

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)